Clinical Trial Update: Lenalidomide and Temsirolimus in Treating Patients With Previously Treated Multiple Myeloma [Phase 1]

View source ↗

Summary

This clinical trial update reports on a Phase 1 study evaluating the combination of lenalidomide and temsirolimus in patients with previously treated multiple m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Lenalidomide (lenalidomide)
• Temsirolimus (temsirolimus)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Refractory Multiple Myeloma, Stage II Multiple Myeloma | Phase 1 | Status: COMPLETED